Rodriguez Luis L, Barrera Jose, Kramer Ed, Lubroth Juan, Brown Fred, Golde William T
Agricultural Research Service, US Department of Agriculture, Plum Island Animal Disease Center, Greenport, NY 11944, USA.
Vaccine. 2003 Sep 8;21(25-26):3751-6. doi: 10.1016/s0264-410x(03)00364-5.
A pilot study was carried out in cattle to determine the immunogenicity of a synthetic consensus peptide comprising the G-H loop region of foot-and-mouth disease virus (FMDV) type-O VP1 and a non-VP1 T-helper (Th) epitope. Cattle vaccinated intramuscularly either once (n = 5) or twice (n = 4) with 50 microg of the peptide preparation at a 21-day interval developed antibodies to the peptide as determined by ELISA with the exception of one steer that received a single dose. However, neutralizing antibody titers against FMDV type-O were modest and all animals presented with clinical FMD signs upon challenge 21 days after the last vaccination. In contrast, four of the five animals inoculated with an inactivated FMD type-O commercially prepared vaccine developed neutralizing antibodies and were fully protected against clinical disease following virus challenge 21 days post-vaccination (dpv). Nucleotide sequence comparison of the VP1 region between the challenge virus and RT-PCR products recovered from a lesion of the peptide-vaccinated animal with the highest neutralizing antibody titer 5 days post-challenge (dpc) showed no evidence for selection of a neutralization-resistant mutant. We conclude that although the synthetic peptide induced an antibody response in cattle, it failed to confer protection against FMDV challenge.
在牛身上开展了一项初步研究,以确定一种合成共有肽的免疫原性,该肽包含口蹄疫病毒(FMDV)O型VP1的G-H环区域和一个非VP1辅助性T细胞(Th)表位。以21天的间隔对牛进行一次(n = 5)或两次(n = 4)肌肉注射50微克肽制剂,除一头接受单剂量的公牛外,通过ELISA测定,其余牛均产生了针对该肽的抗体。然而,针对FMDV O型的中和抗体效价适中,并且所有动物在最后一次接种疫苗21天后受到攻击时均出现了口蹄疫临床症状。相比之下,接种市售灭活FMD O型疫苗的五只动物中有四只产生了中和抗体,并且在接种疫苗后21天(dpv)受到病毒攻击后完全免受临床疾病的侵害。对攻击病毒与在攻击后5天(dpc)中和抗体效价最高的肽疫苗接种动物损伤处回收的RT-PCR产物之间的VP1区域进行核苷酸序列比较,未发现选择中和抗性突变体的证据。我们得出结论,尽管合成肽在牛中诱导了抗体反应,但它未能提供针对FMDV攻击的保护作用。